Mylan CEO Heather Bresch says keeping drug price hikes below 10% isn’t the answer

Bresch said the drug pricing model in the U.S. has to change, but offers few suggestions as to how.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.